Biogen (BIIB) revenue was $9.9B in FY2025 (+2% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$9.9B
+2%
2024
$9.7B
-2%
2023
$9.8B
-3%
2022
$10.2B
-7%
2021
$11.0B
-18%
2020
$13.4B
-6%
2019
$14.4B
+7%
2018
$13.5B
+10%
2017
$12.3B
+7%
2016
$11.4B
+6%
2015
$10.8B
+11%
2014
$9.7B
+40%
2013
$6.9B
+26%
2012
$5.5B
+9%
2011
$5.0B
+7%
2010
$4.7B
+8%
2009
$4.4B
+7%
2008
$4.1B
+29%
2007
$3.2B
Recent Quarterly Revenue
Quarter
Revenue
Q1 2026
$2.5B
Q4 2025
$2.3B
Q3 2025
$2.5B
Q2 2025
$2.6B
Q1 2025
$2.4B
Q4 2024
$2.5B
Q3 2024
$2.5B
Q2 2024
$2.5B
Q1 2024
$2.3B
Q4 2023
$2.4B
Q3 2023
$2.5B
Q2 2023
$2.5B
Source: BIIB on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.